Business description: RushNet, Inc.

RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.

Sales by Activity: RushNet, Inc.

Fiscal Period: December 2020 (USD) 2021 (USD)

Billing Services

4.39M 5.85M

Laboratory Testing Fees

- 1.8M

Intersegment Revenue

- -1.75M

Geographical breakdown of sales: RushNet, Inc.

Fiscal Period: December 2020 (USD) 2021 (USD)

United States

4.39M 5.9M

Executive Committee: RushNet, Inc.

Manager TitleAgeSince
Chief Executive Officer - 04/03/2024
Chief Operating Officer 45 02/08/2021

Composition of the Board of Directors: RushNet, Inc.

Director TitleAgeSince
Chairman - 04/03/2024

Shareholders: RushNet, Inc.

NameStocks%Valuation
Coston, McIsaac & Partners, Inc.
0.000306 %
25,000 0.000306 % - $

Company details: RushNet, Inc.

RushNet, Inc.

8465 Merchants Way

32222, Orange Park

+

address RushNet, Inc.(RSHN)

Management Consulting Services

Change 5-day change 1-year change 3-year change Capi.($)
+4.46%+9.10%-10.51%+63.10% 6.82B
-1.02%+0.65%-10.19%-18.93% 4.15B
+3.39%+11.30%+20.65% - 2.4B
-1.65%+5.47%+74.53%+2,469.44% 1.84B
-1.00%+3.61%-11.31%-31.53% 1.6B
+1.54%+5.20%-9.41%-7.06% 1.32B
+1.64%+3.79%+127.44% - 1.03B
-0.23%-1.35%-31.67%-24.63% 790M
+0.47%+1.30%-8.05%+10.93% 784M
Average +0.81%+3.41%+15.72%+351.62% 2.3B
Weighted average by Cap. +1.59%+3.99%+6.86%+279.47%